Meet the Young Scientists

Emily Bernstein, PhD is an Assistant Professor in the Departments of Oncological Sciences and Dermatology at Icahn School of Medicine. She has made important scientific contributions to various areas of biology during her career, including understanding the mechanisms of RNA interference and chromatin regulation, and more recently, how the latter can impact on disease. Her laboratory studies epigenetic mechanisms underlying cancer initiation and progression, with a focus on malignant melanoma, and stem cell biology. Her goal is to identify chromatin regulators that can be targeted therapeutically for melanoma patients. Dr. Bernstein earned her BSc with honors in genetics from McGill University in 1998 and her PhD in genetics from Stony Brook University/Cold Spring Harbor Laboratory in 2003. She held a postdoctoral fellowship at The Rockefeller University supported by the National Science Foundation before joining the Mount Sinai faculty in 2008. Dr. Bernstein was recently the recipient of a Tisch Cancer Institute Development Fund Award, along with Patrick O.M. Emanuel, MD, and Stephen E. Mercer, MD, PhD for their study "Epigenetic Profiling of Malignant Melanoma". These awards foster collaborative efforts among Mount Sinai laboratory scientists and clinical researchers. Dr. Bernstein has also been honored with a prestigious Ellison Medical Foundation New Scholar Award, a Research Scholar Award from the American Skin Association, and a New York State Department of Health NYSTEM IDEA Award. She is currently the principal investigator for two grants supported by the NCI/NIH focused on her epigenetic studies of melanoma. Learn more about Dr. Bernstein.


Jerry E. Chipuk, Ph.D. is an Assistant Professor in the Departments of Oncological Sciences and Dermatology at Icahn School of Medicine. His laboratory focuses on the mitochondrial pathway of apoptosis with a particular interest in the BCL-2 family of proteins and mitochondria. The main goal of his research program is to understand how the BCL-2 family functions in the context of the cellular milieu to gain fundamental insights into the physiological and pathophysiological mechanisms of apoptosis. Recently, he received the Basil O’Connor Starter Scholar Research Award from the March of Dimes, and funding through the National Cancer Institute. Throughout the years, his work has been published in numerous high-impact journals including Nature and Science. Dr. Chipuk earned a Ph.D. from Case Western Reserve University, and performed post-doctoral training at the La Jolla Institute of Allergy and Immunology and St. Jude’s Children Research Hospital. Learn more about Dr. Chipuk


Hanna Y. Irie, MD, PhD is an Assistant Professor in the Departments of Medicine and Oncological Sciences at Icahn School of Medicine. Her research focuses on identifying and characterizing novel genes and signaling pathways that regulate survival and metastases of breast tumor cells, with the goal of evaluating these candidate genes as therapeutic targets. Specifically, Dr. Irie has investigated the contribution of insulin-like growth factor (IGF-1) and Akt signaling in breast cancer cell survival, and has combined genomic and proteomic approaches to identify novel candidate genes critical for the growth of human breast tumors driven by these oncogenes. Dr. Irie has received numerous awards, honors, and grants, including an NCI/NIH Mentored Clinical Scientist Award , an ASCO Young Investigator Award, an American Cancer Society Fellowship and a Terri Brodeur Breast Cancer Research Foundation Grant,.She received her M.D. and Ph.D. degrees from Harvard Medical School and completed a residency in Internal Medicine at Massachusetts General Hospital in Boston, MA. She subsequently completed a clinical fellowship in adult medical oncology at the Dana-Farber Cancer Institute and a post-doctoral research fellowship in the Department of Cell Biology at Harvard Medical School. Learn more about Dr. Irie


Samuel Sidi, PhD is an Assistant Professor in the Departments of Medicine and Developmental and Regenerative Biology at Icahn School of Medicine. His research focuses on cancer target discovery in zebrafish (genetic and chemical-genetic approaches), mechanism of action of targeted therapies, and development of molecular diagnostics. Dr. Sidi received his PhD in Genetics from the Max-Planck Institute for Developmental Biology, Eberhard Karls Universität, Tübingen, Germany and Ecole Normale Superieure, Paris VI University, Paris, France. He completed his post-doctoral training at the Dana-Farber Cancer Institute, Harvard Medical School, Boston. Dr. Sidi has published papers in numerous scientific journals, including Cell, Science, and the Journal of Neuroscience. In 2009, he received the Claudia Adams Barr Award in Cancer Research for his study Genetic Dissection of Chk1-Suppressed Apoptosis. Most recently, he was named a Scholar by the highly prestigious Searle Scholars program, which every year selects the 15 most promising young scientists nation-wide to fund high risk/high reward research projects. Learn more about Dr. Sidi

 


Contact Us

For more information, please contact Maura Lynch, Director of Development, Tisch Cancer Institute

Tel: 212-659-8500
Send e-mail

Office of Development
One Gustave L. Levy Place
Box 1049
New York, New York 10029-6574

Make a Donation

Donate online to Mount Sinai’s Young Scientist Cancer Research Fund (YSCRF), which enables young, motivated, and bright scientists to pursue innovative cancer research.